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Introduction
Orderly progression through M phase requires appropriately 
timed inactivation of mitotic regulatory proteins by ubiquitin-
dependent proteolysis, with the anaphase-promoting complex/
cyclosome (APC/C) serving as the E3 ligase (Peters, 2006). The 
most critical function of the APC/C is to initiate sister chroma-
tid separation at the metaphase to anaphase transition. It does so 
by  ordering  the  destruction  of  two  key  anaphase  inhibitors,   
securin and cyclin B1 (Sullivan and Morgan, 2007). Earlier in 
mitosis, immediately after initiation of nuclear envelope break-
down (NEBD), APC/C mediates the destruction of cyclin A2 
and Nek2a (Geley et al., 2001; Hames et al., 2001), although it 
is not fully clear why these regulators need to be destroyed in 
prometaphase. After  anaphase  onset, APC/C  remains  active, 
mediating  the  degradation  of  various  proteins  that  regulate   
mitosis or cytokinesis, including Plk1, aurora A, and aurora B 
(Pines, 2006). APC/C has two activating subunits, Cdc20 and 
Cdh1, which function in substrate recruitment and are thought 
to induce changes in APC/C conformation that increase activity 
(Peters, 2006). Cdc20 is APC/C’s early coactivator responsible 
for driving metaphase cells into anaphase (Yu, 2007). Cdh1 is 
kept inactive during the early stages of mitosis by Cdk1-dependent 
phosphorylation (Zachariae et al., 1998) but becomes active when 
Cdk1 activity subsides after APC/C
Cdc20-mediated destruction 
of cyclin B1 in late metaphase. Cdh1-activated APC/C targets 
Cdc20 for destruction in anaphase, allowing Cdh1 to become 
the sole APC/C activator during late mitosis and cytokinesis.
Timing of cyclin B1 and securin ubiquitination by APC/C 
is controlled by the mitotic checkpoint, a surveillance network 
that functions to promote accurate chromosome separation by 
delaying anaphase onset until proper spindle attachment of 
all mitotic chromosomes has been achieved (Musacchio and 
Salmon, 2007; for review see Holland and Cleveland, 2009). At 
mitosis onset, core mitotic checkpoint proteins, including mem-
bers of the Bub and Mad protein families, start to accumulate at 
kinetochores of unattached chromosomes to generate a diffusible 
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B1/Cdk1–dependent phosphorylation, cleaves the Scc1 subunit 
of the cohesin complex that holds sister chromatids together, 
inducing the physical separation of sister chromatids by spindle 
forces (Nasmyth and Haering, 2005; Peters et al., 2008).
Although  previous  studies  have  firmly  established  that 
Cdc20 is an essential activator of sister chromatid separation at 
metaphase to anaphase transition in mammals (Li et al., 2007; 
Wolthuis et al., 2008), the full range of Cdc20 functions is unclear 
at present. In addition to being localized in the mitotic cytosol, 
Cdc20 associates with centrosomes throughout the cell cycle 
and accumulates at unattached kinetochores early in mitosis 
(Kallio et al., 2002). However, little is known about the functional 
signal that acts to prevent polyubiquitination of securin and cyclin 
B1 by APC/C. It is assumed that the inhibitory signal consists of 
Mad2 that has been primed by kinetochore-associated Mad1–Mad2 
to stably interact with the APC/C-activating subunit Cdc20 
(Yu, 2006; Musacchio and Salmon, 2007; Kulukian et al., 2009). 
Mad2-bound Cdc20 is then loaded onto soluble BubR1–Bub3 
complexes, which presumably present Cdc20 as a substrate to 
the APC/C, targeting it for degradation (Nilsson et al., 2008). 
Upon attachment of the last chromosome pair, the inhibitory 
signal is quenched and APC/C is activated by Cdc20, triggering 
the destruction of cyclin B1 and securin. Separase, a protease 
that is held in an inactive state by securin binding and cyclin 
Figure  1.  Generation  of  mice  with  graded 
reduction in Cdc20 dosage. (A) Cdc20 gene 
targeting strategy. Part of the Cdc20 locus (+),   
the targeting vector, the hypomorphic allele   
(Cdc20
H),  EcoR1  restriction  sites,  and  the 
Southern probe are indicated. (B) Cdc20
 
allele from gene trap ES cell clone XE368.   
(C) Southern blot analysis of mice with the indi-
cated Cdc20 genotypes. (D) PCR-based geno-
type analysis of Cdc20 mutant mice. Positions 
of PCR primers (a–e) are indicated in A and B.   
(E)  Western  blot  analysis  of  MEF  extracts 
for Cdc20. Cdc20 protein levels in MEFs of 
Cdc20
/H  mice  were  15–20%  of  normal.   
(F) Western blot analysis of extracts of the in-
dicated tissues and cell types for Cdc20. Actin 
served as a loading control.315 Cyclin B1 is newly synthesized in mitosis • Malureanu et al.
Cdc20
+/, Cdc20
H/H, and Cdc20
/H MEFs had a graded reduc-
tion of Cdc20 protein (Fig. 1 E). Similar gradations of Cdc20 
reduction were observed in the testis and ovary (not depicted). 
Western blot analysis of extracts from thymus, liver, lung, and 
lung fibroblasts of Cdc20
+/+ and Cdc20
/H mice further indi-
cated that the observed Cdc20 protein reductions are general-
ized (Fig. 1 F).
Graded Cdc20 reduction causes 
progressive aneuploidy
Previous  studies  have  documented  that  complete  (Li  et  al., 
2007) or near-complete (<5% of normal; Wolthuis et al., 2008) 
depletion of Cdc20 precludes chromosome separation and ana-
phase onset. At less-profound reductions of Cdc20 expression 
(10% of normal Cdc20), cultured cells can execute anaphase 
and complete mitosis (Wolthuis et al., 2008). However, whether 
subnormal Cdc20 levels affect the accuracy of the chromosome 
separation process has not been investigated. To address this 
key question, we performed chromosome counts on metaphase 
spreads of Cdc20
+/+, Cdc20
+/, Cdc20
H/H, and Cdc20
/H MEFs. 
We found that 12% of Cdc20
+/+ MEFs were aneuploid (Table I). 
In contrast, Cdc20
+/, Cdc20
H/H, and Cdc20
/H MEFs had 17%, 
23%, and 27% aneuploidy, respectively, uncovering an inverse 
correlation between the level of Cdc20 protein and the incidence 
of numerical chromosome abnormalities in these cells. In addi-
tion, we observed modest yet statistically significant increases 
in premature sister chromatid separation (PMSCS) at all levels 
of Cdc20 reduction, with Cdc20
+/, Cdc20
H/H, and Cdc20
/H 
MEFs showing PMSCS in 10%, 11%, and 12% of mitotic fig-
ures, respectively, compared with 3% in Cdc20
+/+ mitotic fig-
ures  (Table  I).  Differences  among  Cdc20
+/,  Cdc20
H/H,  and 
Cdc20
/H MEFs were marginal, suggesting that there is no clear 
relationship between PMSCS and the level of Cdc20 reduction 
in MEFs. MG132 treatment of Cdc20
/H MEFs prevented 
PMSCS (Table I), indicating that the PMSCS phenotype is un-
likely to be caused by a defect in Sgo1-mediated protection of 
centromeric cohesion.
Next, we performed chromosome counts on splenocytes 
of Cdc20
+/+, Cdc20
+/, Cdc20
H/H, and Cdc20
/H mice at 5 mo of 
age. These splenocytes were cultured only 5 h so that detected 
chromosome number aberrations represent in vivo–acquired aneu-
ploidies. Although Cdc20
+/+ splenocytes had 40 chromosomes, 
subnormal Cdc20 expression caused substantial aneuploidization, 
significance of centrosome- and kinetochore-associated Cdc20 
in mitosis. Interestingly, centrosome-associated Cdc20 has re-
cently been implicated in dendrite morphogenesis of postmi-
totic neurons, presumably by triggering the polyubiquitination 
and  subsequent  degradation  of  Id1,  a  centrosome-associated 
protein that is known to inhibit dendrite growth (Kim et al., 
2009). The subsequent discovery that neurons also require 
Cdc20 for the formation of presynaptic sites (Yang et al., 2009) 
underscores the hypothesis that Cdc20 has important functions 
outside of mitosis. However, whether Cdc20 depletion is asso-
ciated with any neuropathology remains an open question. It is 
also unknown whether Cdc20 dysfunction leads to inaccurate 
chromosome segregation and aneuploidy, and if so, whether 
this would increase the risk for neoplastic transformation.
In-depth analysis of the Cdc20 functions in mitosis, nor-
mal development, and oncogenesis has been precluded by early 
embryonic lethality of Cdc20 knockout mice (Li et al., 2008). 
We bypassed this problem by generating mutant mouse strains 
in which the dose of Cdc20 is reduced in graded fashion. Using 
mice and mouse embryonic fibroblasts (MEFs) with low amounts 
of Cdc20, we have obtained important new insights into the in 
vivo functions of Cdc20 and the regulation of cyclin B1 expres-
sion in mitosis.
Results
Generation of mice with graded reduction 
in Cdc20
Null mice for the Cdc20 gene die as two–cell stage embryos be-
cause of failed anaphase onset (Li et al., 2007). To further ex-
plore the physiological significance of Cdc20, we generated a 
series of mutant mouse strains in which expression of Cdc20 is 
gradually reduced by using various combinations of wild-type 
(Cdc20
+), hypomorphic (Cdc20
H), and knockout (Cdc20
)   
alleles. The Cdc20
H allele was produced by targeted insertion of a 
neomycin resistance cassette into the third intron of the Cdc20 
gene (Fig. 1, A–C). The Cdc20
 allele was obtained from gene 
trap mouse embryonic stem (ES) cell clone XE368 (Fig. 1,   
B and D). It has been shown that this gene trap allele is the equiv-
alent of a null allele (Li et al., 2007). In contrast to Cdc20
/ 
mice, Cdc20
+/H, Cdc20
+/, Cdc20
H/H, and Cdc20
/H mice were 
born alive and were overtly indistinguishable from their Cdc20
+/+ 
counterparts. Western blot analysis demonstrated that Cdc20
+/H, 
Table I.  Graded reduction of Cdc20 in MEFs induces progressive aneuploidy
Mitotic MEF genotype
a Aneuploid figs. Karyotypes w/ indicated chromosome No. Mitotic figs. w/ PMSCS Mitotic figs. w/ PMSCS in 
MG132
37 38 39 40 41 42 43
% %
+/+ 12 (2) 1 2 5 132 7 3 NA 3 (1) 0 (0)
Cdc20
+/ 17 (1) 1 NA 11 124 10 4 NA 10 (1) NA
Cdc20
H/H 23 (2) NA 5 9 115 18 3 NA 11 (2) NA
Cdc20
/H 27 (1) 3 4 9 110 14 7 3 12 (1) 0 (0)
150 mitotic figures were inspected. NA, not applicable. Numbers in parentheses indicate SD. Karyotyping was performed at passage 5. MG132 treatment was for 
2 h in 10 µM of the drug.
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than nontreated Cdc20
/H MEFs (Fig. 2, D–F). Immunostaining 
of Cdc20
/H MEFs for tubulin and centromeric proteins revealed 
that misaligned chromosomes consist of duplicated sister chro-
matids captured by MTs emanating from a single spindle pole 
(Fig. 2 G). At a low temperature, these kinetochore MT fibers 
(K-fibers) depolymerized, indicating that MT–kinetochore attach-
ments at misaligned chromosomes were unstable (Fig. 2 H). In 
contrast, aligned chromosomes of Cdc20
/H MEFs had K-fiber 
attachments that were stable in the cold. Intersister kinetochore 
distances of misaligned chromosomes of Cdc20
/H MEFs were 
greatly reduced compared with those of bioriented chromosome 
pairs of Cdc20
+/+ MEFs, a finding that is consistent with monotelic 
or syntelic attachment (Fig. 2 I). In contrast, aligned chromosomes 
of Cdc20
/H MEFs had normal inter sister kinetochore distances, 
indicating that they were under proper tension. Collectively, the 
presence of misaligned chromosomes with monopolar attach-
ments even after prolonged metaphase arrest suggests a require-
ment for Cdc20 in efficient kinetochore–MT attachment.
Accumulation of Cdc20 at unattached 
kinetochores is reduced in Cdc20
/H MEFs
Cdc20 is present in the mitotic cytosol, where it serves as an 
activator of APC/C, but it also localizes at kinetochores where 
its function is unknown (Kallio et al., 2002). Consistent with ear-
lier findings in human cell lines (Kallio et al., 2002), high levels 
of  Cdc20  accumulated  at  kinetochores  of  Cdc20
+/+  MEFs   
during the early stages of mitosis (Fig. 3 A). In contrast, most 
kinetochores of Cdc20
/H MEFs showed greatly reduced Cdc20 
immunostaining at corresponding stages of mitosis. This reduc-
tion does not seem to be part of a more generalized kinetochore 
assembly problem because Cdc20
/H MEFs accumulated normal 
amounts of Bub1, BubR1, Mad1, Mad2, and centromere protein E 
(CENP-E) at kinetochores (Fig. S1; and not depicted). Further-
more, aurora B and MCAK, two key components of a mecha-
nism that resolves aberrant chromosome attachments, properly 
localized to the inner centromeric regions of Cdc20
/H meta-
phases (unpublished data). We noticed that kinetochores of 
chromosomes that were not properly aligned in the spindle 
equator of Cdc20
+/+ metaphases accumulated higher levels of 
Cdc20 than kinetochores of properly bioriented chromosomes 
(Fig. 3 B). Kinetochores of unaligned chromosomes of Cdc20
/H 
MEFs also stained more intensely than kinetochores of aligned 
chromosomes but were less bright than their counterparts in 
Cdc20
+/+ MEFs. These data raise the intriguing possibility that 
with Cdc20
+/, Cdc20
H/H, and Cdc20
/H showing 15%, 17%, 
and 21% aneuploidy, respectively (Table II). The incidence of 
PMSCS in mutant splenocytes was modestly increased (Table II), 
but again, there was no clear correlation between PMSCS and 
Cdc20 dosage. Chromosome counts on cultured primary lung 
fibroblasts from Cdc20
+/+ (8% aneuploidy) and Cdc20
/H mice 
(19% aneuploidy) further suggested that aneuploidy is a common 
consequence of Cdc20 hypomorphism, irrespective of cell type.
Cdc20 loss leads to chromosome 
misalignment and chromatin bridging
To explore how Cdc20 deficiency creates aneuploidy, we moni-
tored the chromosome movements of Cdc20
+/+ and Cdc20
/H 
MEFs undergoing mitosis using time-lapse live cell microscopy. 
Chromosomes were visualized by transduction of cells with a 
lentivirus encoding YFP-H2B. Our analysis revealed three types 
of errors: chromosome misalignment, chromosome lagging, and 
chromatin bridge formation (Fig. 2, A–C). Of these, chromo-
some lagging occurred at similar rates in Cdc20
/H and Cdc20
+/+ 
MEFs, indicating that this defect is unlikely to be caused by 
Cdc20 depletion. The other two defects, however, were substan-
tially increased at low Cdc20 levels, with 9% of Cdc20
/H MEFs 
showing misalignment (vs. 1% of Cdc20
+/+ MEFs) and 10% 
having bridges (vs. 0% of Cdc20
+/+ MEFs). Most cells had either 
a single misaligned chromosome (Fig. 2 B) or a single chroma-
tin bridge (Fig. 2 C).
Resolution of chromatin bridges might cause structural 
chromosome  damage  such  as  chromosome  gaps  and  breaks 
(Sotillo et al., 2007), but screening of Giemsa-stained meta-
phase spreads of Cdc20
/H MEFs and splenocytes revealed no 
evidence for such damage (unpublished data). Formation of chro-
matin bridges has been associated with aberrant inner centromere 
targeting of Topo II during the early stages of mitosis (Dawlaty 
et al., 2008), but no such defect was observed in Cdc20
/H MEFs 
(unpublished data).
To  further  characterize  the  chromosome  misalignment 
phenotype, we performed live cell imaging on Cdc20
/H MEFs 
in the presence of MG132, a proteasome inhibitor that extends 
metaphase  by  preventing  cyclin  B1  and  securin  degradation 
(Lee and Goldberg, 1998). Instead of improving the misalign-
ment phenotype by allowing more time for establishment of 
kinetochore–microtubule (MT) attachment, MG132 exacerbated 
it as the incidence of congression failure, and the number of 
misaligned chromosomes were substantially higher in treated 
Table II.  Progressive reduction of Cdc20 in splenocytes leads to increasing aneuploidy
Mitotic MEF  
genotype
Age Aneuploid figures Karyotypes w/ indicated chromosome No. Mitotic figures w/ 
PMSCS
37 38 39 40 41 42
% %
+/+ 5 mo (3) 0 (0) NA NA NA 150 NA NA 0 (0)
Cdc20
+/ 5 mo (3) 15 (1) 1 5 5 124 10 5 7 (1)
Cdc20
H/H 5 mo (3) 17 (1) NA 3 8 125 7 7 10 (1)
Cdc20
/H 5 mo (3) 21 (1) NA 4 9 119 10 8 11 (1)
150 mitotic figures were inspected. NA, not applicable. Numbers in parentheses indicate SD.317 Cyclin B1 is newly synthesized in mitosis • Malureanu et al.
key mitotic regulators whose timely destruction might be required 
for accurate chromosome separation. To explore this scenario, 
we measured endogenous cyclin A2 and B1 levels of Cdc20
+/+ 
and Cdc20
/H MEFs at various stages of mitosis by indirect 
immunofluorescence. Consistent with earlier work (van Ree et al., 
2010),  cyclin A2  was  present  at  high  levels  in  prophase  of 
Cdc20
+/+ MEFs and promptly degraded as cells progressed to 
Cdc20 exerts its influence on efficient MT–kinetochore capture 
through its kinetochore-associated fraction.
Cyclin B1 levels of Cdc20 hypomorphic 
cells rise in metaphase
Another possibility is that reduced levels of Cdc20 in the mitotic 
cytosol result in low APC/C activity, thereby perhaps stabilizing 
Figure 2.  Cdc20 is required for proper chromo-
some alignment and segregation. (A) Analysis of 
chromosome segregation errors in Cdc20
+/+ 
and  Cdc20
/H  MEFs  by  live  cell  imaging.   
(B and C) Live cell images of H2B-YFP–positive   
Cdc20
/H  MEFs  showing  chromosome  mis-
alignment (B) and bridging (C) during unchal-
lenged mitosis. (D and E) Live cell images 
of  10  µM  MG132-treated  H2B-YFP–positive   
Cdc20
/H MEFs showing minor (D) and major 
chromosome misalignments. (B–E) Misaligned 
chromosomes  are  marked  by  arrows,  and 
chromatin bridges are marked by arrowheads. 
(F)  Quantification  of  MEFs  with  misaligned 
chromosomes  in  MG132.  Shaded  and  non-
shaded areas denote cells with minor (≤2) and 
major  (≥3)  chromosomal  misalignments,  re-
spectively. Error bars represent SD. (G) Images 
of  MG132-treated  Cdc20
+/+  and  Cdc20
/H 
MEFs immunostained for tubulin (green), kineto-
chores (red), and DNA (blue). Insets highlight 
MT–kinetochore  interactions.  (H)  Analysis  of 
MT–kinetochore attachments in the cold (green, 
MTs; red, kinetochores). Insets show details of 
cold stable or cold unstable MT–kinetochore 
interactions (the inset of the Cdc20
/H cells in-
cludes Hoechst staining to visualize sister chro-
matids). (I) Analysis of the distance between 
sister kinetochores in Cdc20
+/+ and Cdc20
/H 
MEFs. Kinetochores were visualized by ACA 
immunostaining.  Cells  were  costained  for 
MTs (-tubulin) and DNA (Hoechst) to iden-
tify bioriented and misaligned chromosomes. 
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prometaphase (Fig. 4, A and B). The exact same degradation 
pattern was observed in Cdc20
/H MEFs, indicating that Cdc20 
levels of these cells meet the threshold for efficient destruction 
of cyclin A2.
As expected, cyclin B1 levels gradually declined from pro-
metaphase to anaphase in Cdc20
+/+ MEFs (Fig. 4 B). In contrast, 
instead of decreasing from prometaphase to metaphase, cyclin B1 
levels markedly increased in Cdc20
/H MEFs (Fig. 4, C and D). 
Furthermore, when Cdc20
/H MEFs entered anaphase, they did 
so with elevated levels of cyclin B1 compared with Cdc20
+/+ 
MEFs. These data suggest that Cdc20 seems to be rate limiting 
for timely destruction of cyclin B1. By immunofluorescence, 
Cdc20
/H metaphases and anaphases showed elevated levels of 
phosphorylated Cdk substrates (Fig. 4, E and F), suggesting that 
the rise in cyclin B1 expression resulted in increased cyclin B1–
Cdk1 activity. Furthermore, these results imply that residual 
Cdk1 activity is not a barrier for anaphase entry.
Next, we examined whether securin destruction was also 
delayed in Cdc20
/H MEFs. Because endogenous securin is not 
detectable in Cdc20
+/+ and Cdc20
/H MEFs by immunostaining 
(unpublished data), we decided instead to monitor the destruc-
tion of ectopically expressed securin-EYFP fusion protein by 
live cell microscopy. Unlike cyclin B1, securin-EYFP levels did 
not rise in mitotic Cdc20
/H MEFs (Fig. S2). However, although 
Cdc20
/H MEFs had quite normal rates of securin-EYFP de-
struction, the onset of degradation was substantially delayed 
compared with Cdc20
+/+ MEFs, indicating that there is a critical 
Cdc20 threshold for proper timing of securin degradation.
Cyclin B1 is de novo synthesized in mitosis
The rise in cyclin B1 levels from prometaphase to metaphase in 
Cdc20
/H MEFs was intriguing, which prompted us to further ex-
plore the underlying mechanism. To test whether the increase was 
dependent on de novo protein synthesis, Cdc20
+/+ and Cdc20
/H 
MEFs were treated with cycloheximide (CHX) for 10 min and 
immediately fixed and stained for cyclin B1. Although inhibi-
tion of protein biosynthesis had limited impact on cyclin B1 
protein levels in Cdc20
+/+ metaphases, it prevented the increase 
in cyclin B1 that is characteristic for Cdc20
/H metaphases (Fig. 4, 
G and H). Earlier work in HeLa cells suggests that the cyclin B1 
gene promoter is transcriptionally active in mitosis (Sciortino   
et al., 2001), but actinomycin D treatment failed to have an im-
pact on de novo synthesis of cyclin B1 in Cdc20
/H metaphases 
(Fig.  S3,  A  and  B).  Together,  these  results  suggested  that 
Cdc20
/H MEFs produce cyclin B1 in mitosis via a mechanism 
that involves translation of preexisting cyclin B1 transcripts.
To evaluate whether cyclin B1 synthesis in mitosis is also 
a feature of normal cells, we treated wild-type MEFs with no-
codazole for 15 min before fixation for cyclin B1 staining. As 
shown in Fig. 5 (A and B), nocodazole-treated cells showed 
significantly higher cyclin B1 immunofluorescence than untreated 
prophases, prometaphases, and metaphases, implying that MT 
depolymerization leads to increased cyclin B1 expression. This 
increase was significantly blunted when cells were treated si-
multaneously with nocodazole and CHX, indicating that it in-
volved de novo cyclin B1 synthesis. To complement these staining 
experiments with biochemical data, we collected HeLa cells by 
Figure  3.  Unattached  kinetochores  of  hypomorphic  MEFs  have  low 
Cdc20 levels. (A) Kinetochore localization of Cdc20 during early mitotic 
stages  of  Cdc20
+/+  and  Cdc20
/H  MEFs.  P,  prophase;  PM,  prometa-
phase;  M,  metaphase.  (B)  Images  of  Cdc20
+/+  and  Cdc20
/H  meta-
phases with misaligned chromosomes (arrows) stained for Cdc20 and 
centromeres. Arrowheads mark kinetochores with high Cdc20 levels that 
are out of focus. Bars, 10 µm.319 Cyclin B1 is newly synthesized in mitosis • Malureanu et al.
Figure 4.  Cyclin B1 levels spike during metaphase of Cdc20 hypomorphic cells. (A) Immunostaining of Cdc20
+/+ and Cdc20
/H prophases (P), prometa-
phases (PM), and metaphases (M) for cyclin A2. (B) Quantification of cyclin A2 signals in A (n = 26 Cdc20
+/+ prophases, 10 Cdc20
+/+ prometaphases, 
and 5 Cdc20
+/+ metaphases; n = 23 Cdc20
/H prophases, 8 Cdc20
/H prometaphases, and 5 Cdc20
/H metaphases). Error bars represent SD. (C) MEFs 
at the indicated mitotic stages (A, anaphase) stained for cyclin B1. (D) Quantification of cyclin B1 signals (n = 11–15 cells/stage). Error bars represent 
SEM. *, P < 0.003 versus wild-type (unpaired t test); **, P < 0.01 versus wild-type (unpaired t test). (E) MEFs at the indicated mitotic stages stained for cyclin B1   
and phosphoserine Cdk substrates. (F) Quantification of phosphoserine Cdk substrate signals. *, P < 0.05 versus Cdc20
/H prometaphase (unpaired   
t test). Error bars represent SEM (n = 8 cells for each group). (G) Cdc20
/H metaphases stained for cyclin B1 after treatment with 1 µg/ml CHX for 10 min. 
(H) Quantification of cyclin B1 signals (n = 10 cells). *, P < 0.0001 versus nontreated (unpaired t test). Error bars represent SEM. Bars, 10 µm.JCB • VOLUME 191 • NUMBER 2 • 2010   320
accumulate  cyclin  B1–Venus  in  mitosis  (unpublished  data). 
Collectively, these data strongly suggest that de novo synthesis 
of cyclin B1 during mitosis is driven by CPEB-dependent tran-
scriptional control.
Cdc20 hypomorphism delays  
anaphase onset
The finding that the onset cyclin B1–Venus degradation was 
consistently  delayed  in  Cdc20
–/H  MEFs  suggested  that  the 
timing of mitosis was altered in these cells. However, it can-
not be excluded that the cyclin B1–Venus overexpression in 
these experiments is at least in part responsible for the delay. 
To assess the true impact of Cdc20 hypomorphism on mitotic 
timing,  we  followed  mRFP-H2B–positive  Cdc20
+/+  and 
Cdc20
/H MEFs through mitosis and calculated the duration 
of each mitotic stage. Cells showing aberrant chromosome 
segregation were excluded from the analysis, as altered mi-
totic timing in these cells might simply be caused by pro-
longed mitotic checkpoint activation. We found that prophase, 
defined in this study as the period between chromosome con-
densation and the start of NEBD, was significantly acceler-
ated in Cdc20
/H MEFs, whereas prometaphase showed normal 
timing (Fig. 7 A). However, metaphase was significantly de-
layed when Cdc20 levels were low, with Cdc20
+/+ MEFs exe-
cuting metaphase on average in 11 min versus Cdc20
/H MEFs 
in 18 min. The duration of anaphase was normal, although 
Cdc20
/H MEFs had elevated cyclin B1 levels at this stage of 
mitosis. To examine whether the observed increase in cyclin B1 
expression in Cdc20
/H metaphases might be linked to the 
delay  in  anaphase  onset,  we  repeated  the  aforementioned   
experiment in the presence of CHX to prevent de novo cyclin B1 
synthesis. Only cells that entered mitosis within 10 min after 
adding CHX to the culture medium were analyzed to pre-
clude that alterations in mitotic timing might stem from pro-
tein biosynthesis deficiencies in G2 phase. Consistent with 
the notion that high cyclin B1 levels prolong metaphase, 
CHX  restored  normal  metaphase  timing  in  Cdc20
/H  MEFs 
(Fig. 7 A). Notably, inhibition of protein biosynthesis had no 
significant impact on the timing of the various mitotic stages 
in Cdc20
+/+ MEFs.
Given that Cdc20 is the main target of the mitotic check-
point, we wondered whether Cdc20 hypomorphism affects 
the activity of this checkpoint. To measure the checkpoint 
status, we used an established live cell imaging–based no-
codazole challenge assay. In this assay, YFP-H2B–positive 
Cdc20
+/+ and Cdc20
/H MEFs were exposed to nocodazole to 
activate the mitotic checkpoint, and the time between NEBD 
and DNA decondensation is measured (Baker et al., 2006; 
van Ree et al., 2010). Cells with an intact checkpoint arrest in 
prometaphase for a prolonged period of time before exiting 
mitosis without chromosome separation. The duration of this 
period was on average 4.8 h for our Cdc20
+/+ MEFs (Fig. 7 B). 
Cdc20
/H MEFs exited mitosis slightly faster, but the differ-
ence  with Cdc20
+/+  MEFs  was  not  statistically  significant. 
Similar results were obtained when paclitaxel was used in-
stead of nocodazole (Fig. 7 B). Thus, the mitotic checkpoint 
seems to function properly at low amounts of Cdc20 and is 
mitotic shake off (without nocodazole) and cultured the har-
vested mitotic cells for 15 min in medium containing either no-
codazole alone or both nocodazole and CHX, after which we 
prepared cell extracts and performed Western blot analyses. As 
shown in Fig. 5 C, CHX-treated cells indeed had lower cyclin B1 
levels than their nontreated counterparts. Cdc20, another protein 
that is de novo synthesized during mitosis (Nilsson et al., 2008), 
was also lower, whereas Mad2, cyclin A2, and securin were not. 
Consistent with cyclin B1 protein synthesis during normal   
mitosis, Cdc20
+/+ metaphases that had been exposed to CHX for 
15 min exhibited significantly lower cyclin B1 immunofluores-
cence than untreated counterparts (Fig. 5, D and E). Very simi-
lar results were obtained for HeLa cells (Fig. 5, F and G).
The 3 untranslated region (UTR) of cyclin 
B1 regulates de novo synthesis in mitosis
To obtain additional evidence for de novo synthesis of cyclin B1 
in mitosis, we followed cyclin B1–Venus protein levels in living 
Cdc20
/H and Cdc20
+/+ MEFs using time-lapse microscopy.   
In Cdc20
+/+ MEFs, cyclin B1–Venus levels were quite stable 
until 6 min after NEBD, after which they rapidly declined 
(Fig. 6, A and B). Surprisingly, Cdc20
/H MEFs did not show 
the expected dramatic incline in cyclin B1–Venus in the period 
after NEBD, although a small, statistically insignificant increase 
was  noticeable.  The  onset  of  cyclin  B1–Venus  degradation, 
however, was noticeably delayed.
We reasoned that our cyclin B1–Venus expression plas-
mid might lack critical cyclin B1 elements for expression of the 
protein in M phase. In frogs, the first few embryonic cell divi-
sions after fertilization occur in the absence of gene transcrip-
tion and are dependent on translation of selective oocyte-derived 
mRNAs, including cyclin B1 mRNA (Groisman et al., 2002; 
Richter, 2007). Selective translation of cyclin B1 and other tran-
scripts is mediated by cytoplasmic polyadenylation elements 
(CPEs) in the 3UTRs of these mRNAs, which bind CPE-binding 
protein (CPEB). As fertilized embryos enter M phase, CPEB is 
activated by aurora A phosphorylation at Ser174, which allows 
for poly(A) tail extension and translation initiation (Groisman 
et al., 2002; Richter, 2007). We wondered whether de novo syn-
thesis of cyclin B1 during nonembryonic cell divisions might 
also be mediated by CPEB-dependent translation initiation. If 
so, the lack of cyclin B1 3UTR sequences in our expression 
plasmid might explain why Cdc20
/H MEFs failed to show a 
marked increase in cyclin B1–Venus in mitosis.
To test this hypothesis, we cloned the mouse cyclin B1 
3UTR (Fig. S3 C) downstream of the cyclin B1–Venus coding 
region and repeated the aforementioned experiment. As illus-
trated in Fig. 6 (C and D), immediately after NEBD, cyclin B1–
Venus started to accumulate profoundly in  Cdc20
/H MEFs, 
reaching peak levels 12 min later. Cdc20
+/+ MEFs also showed 
increased cyclin B1–Venus levels after NEBD, but this increase 
was very small compared with that of Cdc20
/H MEFs. Anaphase 
was preceded by a period of rapid cyclin B1–Venus proteolysis 
in both Cdc20
/H and Cdc20
+/+ MEFs. However, the initiation of 
cyclin B1–Venus destruction was considerably delayed in Cdc20 
hypomorphic cells. Importantly, when the cyclin B1 3UTR was 
placed in the antisense orientation, Cdc20
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Figure 5.  Cyclin B1 is de novo synthesized during normal mitosis. (A) Cdc20
+/+ mitotic MEFs increase cyclin B1 levels in response to MT depolymerization 
but not when protein synthesis is blocked with CHX. Cells were either untreated or treated with 100 ng/ml nocodazole (Noc) or 100 ng/ml nocodazole 
+ 1 µg/ml CHX for 15 min. (B) Quantification of cyclin B1 signals (n > 10 cells per group). *, P < 0.02 versus prophase (P), prometaphase (PM), and 
metaphase (M); **, P < 0.001 versus nocodazole + CHX-treated cells (by unpaired t test). (C) Extracts of mitotic HeLa cells treated for 15 min with 
100 ng/ml nocodazole or 100 ng/ml nocodazole and 1 µg/ml CHX analyzed for the indicated proteins by Western blotting. (D) Cdc20
+/+ metaphases 
in which de novo protein synthesis is blocked by CHX show decreased cyclin B1 immunofluorescence. Cells were treated with 1 µg/ml CHX 15 min before 
fixation. (E) Quantification of endogenous cyclin B1 signals (n = 10 Cdc20
+/+ MEFs/group). *, P = 0.0366 versus untreated cells (by unpaired t test). 
(F) As in D but shown for HeLa cells. (G) Quantification of endogenous cyclin B1 signals (n = 10 HeLa cells/group). *, P = 0.0005 versus untreated cells 
(by unpaired t test). Error bars represent SD. Bars, 10 µm.JCB • VOLUME 191 • NUMBER 2 • 2010   322
is  independent  of  mitotic  checkpoint  signaling.  However, 
BubR1-deficient cells failed to enrich Cdc20 at kinetochores 
(Fig. 7 E), suggesting that BubR1 plays a key role in recruit-
ment of Cdc20 to kinetochores.
unlikely  to  be  a  source  of  chromosome  missegregation  in 
Cdc20
/H MEFs. In addition, Cdc20 abundantly accumulated 
at unattached kinetochores in Mad2-depleted Cdc20
+/+ MEFs 
(Fig. 7, C and D), indicating that its kinetochore association 
Figure 6.  Cyclin B1 synthesis in mitosis is mediated by the cyclin B1 3UTR. (A) Time-lapse images of cyclin B1–Venus and H2B-mRFP expressing Cdc20
+/+ 
and Cdc20
/H MEF progression through mitosis. The cyclin B1–Venus expression construct did not include the cyclin B1 3UTR. (B) Cyclin B1–Venus fluores-
cence of Cdc20
+/+ and Cdc20
/H MEFs was quantitated and plotted against the time before and after NEBD. (C and D) Same as in A and B, but in these 
experiments, the cyclin B1–Venus expression construct included the cyclin B1 3UTR. M, metaphase; LM, late metaphase; A, anaphase. Bars, 10 µm.323 Cyclin B1 is newly synthesized in mitosis • Malureanu et al.
extent to which Cdc20 mutant mice are prone to cancer, we treated 
the dorsal skin of Cdc20
+/+, Cdc20
+/, Cdc20
H/H, and Cdc20
/H 
pups with a low dose of the carcinogen 7, 12-dimethylbenz(a)- 
anthracene (DMBA) at 3–5 d after birth (Dawlaty et al., 2008). 
Animals were sacrificed at 5 mo and screened for tumors. Con-
sistent with the literature, this treatment protocol induced 
Cdc20 hypomorphic mice  
are not tumor prone
Mutant mouse strains with aneuploidy are usually susceptible 
to  tumor  development,  particularly  to  carcinogen-induced 
tumorigenesis (for reviews see Ricke et al., 2008; Holland and 
Cleveland, 2009; Schvartzman et al., 2010). To determine the 
Figure  7.  Cdc20  hypomorphism  specifically  pro-
longs  metaphase.  (A)  Analysis  of  mitosis  timing  in 
Cdc20
+/+  and  Cdc20
/H  MEFs  in  the  presence  or 
absence of CHX (n = 10 to 15 cells/group). Error 
bars represent SEM. *, P < 0.0005 versus Cdc20
+/+ 
(by Mann–Whitney test). P, prophase; PM, prometa-
phase; M, metaphase; A, anaphase. (B) Analysis of 
mitotic checkpoint activity of Cdc20
+/+ (n = 64 cells) 
and Cdc20
/H MEFs (n = 68 cells) challenged with 
nocodazole (Noc) or taxol. Error bars represent SD. 
(C) Images of Cdc20
+/+ MEFs in which Mad2 levels 
were normal or depleted by RNA interference. Pro-
metaphases  stained  for  Cdc20,  centromeres,  and 
DNA are shown. (D) Western blot showing that Mad2 
was efficiently depleted. (E) Images of wild-type and 
BubR1
/ prometaphases stained for Cdc20, centro-
meres, and DNA. Bars, 10 µm.JCB • VOLUME 191 • NUMBER 2 • 2010   324
for memory deficits (Fig. S5 G) and the other for motor defi-
cits (Fig. S5 H). When taken together with the observation 
that Cdc20
/H mice have normal health and life spans, the afore-
mentioned data imply that Cdc20 levels in Cdc20
/H mice are 
above the physiologically critical threshold for development of 
overt neuropathology.
Discussion
To address the physiological role of Cdc20, we used a hypo-
morphic approach in mice. We were successful in generating 
viable mice that express 15–25% of normal Cdc20 protein levels. 
Using these mice and cells thereof, we have yielded important 
new insights into the functions of Cdc20 in vivo. Our experi-
ments unveil a hitherto unrecognized requirement for Cdc20 in 
efficient kinetochore–MT attachment and show that partial loss 
of Cdc20 function leads to inaccurate chromosome separation 
and near diploid aneuploidies. Furthermore, our data show that 
cyclin B1 is de novo synthesized in mitosis via CPEB-dependent 
translation, causing accumulation of cyclin B1 in prometaphase 
and, most likely, delayed anaphase onset in Cdc20 hypomorphic 
cells. Remarkably, Cdc20 insufficiency failed to promote tumori-
genesis, which separates Cdc20 from other chromosomal instabil-
ity genes that cause aneuploidy when defective. Cdc20-insufficient 
mice showed no evidence of abnormal brain development or   
neuropathology, which is unexpected given the recently ascribed 
effects of APC/C
Cdc20 ubiquitin signaling on dendrite morpho-
genesis and presynaptic differentiation.
Cdc20 and chromosome–MT attachment
A surprising finding was that cells with low amounts of Cdc20 
are prone to chromosome misalignment. Chromosomes that fail 
to achieve biorientation consist of chromosome pairs attached 
to MTs coming from one spindle pole. Although these MT   
attachments are unstable, the bioriented chromosomes of Cdc20 
hypomorphic cells are stably attached to spindle MTs and are 
under normal tension, suggesting that Cdc20 insufficiency re-
duces the efficiency of MT-capturing process rather than the 
stability of the newly established MT–kinetochore interaction. 
Because Cdc20 is a kinetochore-associated protein, it is con-
ceivable that it exerts its influence on MT–kinetochore attach-
ment from this location. If so, it is unlikely to do so through a 
mechanism that involves kinetochore assembly because various 
kinetochore-associated proteins with key roles in the attach-
ment process, such as Bub1, BubR1, and CENP-E, are normally 
recruited to kinetochores of Cdc20 hypomorphic cells. We find 
that recruitment of Cdc20 to kinetochores is dependent on its 
binding partner BubR1, raising the possibility that Cdc20 might 
exert its effect on MT–kinetochore attachment through BubR1. 
However, BubR1 seems to be more important in stabilizing 
MT–kinetochore attachments rather than their initial MT cap-
ture (Lampson and Kapoor, 2005), arguing against this idea.
Interestingly, kinetochore-associated Cdc20 levels peak in 
prometaphase and drop significantly after biorientation in meta-
phase (Fig. 2, G and H; Kallio et al., 2002). However, Cdc20 
levels remain high at chromosomes that fail to align in the meta-
phase plate, raising the possibility that Cdc20 might play an active 
primarily lung tumors as well as an occasional skin tumor. 
We found that overall, lung, and skin tumor incidence rates 
of Cdc20
+/, Cdc20
H/H, and Cdc20
/H animals were not signifi-
cantly different from those of Cdc20
+/+ mice (Fig. 8, A–C). The 
mean number of lung tumors was lower in Cdc20
+/, Cdc20
H/H, 
and Cdc20
/H mice, but only the decrease in Cdc20
+/ mice 
reached statistical significance (Fig. 8 D). The median number 
of lung tumors was not significantly different among the vari-
ous mouse genotypes (Fig. 8 E).
To determine whether Cdc20 hypomorphic mice are prone 
to spontaneous tumors, Cdc20
+/+ and Cdc20
/H mice were mon-
itored for signs of ill health for nearly 3 yr. Survival curves of 
Cdc20
+/+ and Cdc20
/H mice were overlapping, indicating that 
Cdc20 hypomorphism has no impact on lifespan (Fig. 8 F).   
Tumor-free survival curves were also superimposed, underscor-
ing the conclusion from our tumor bioassay with DMBA that 
mice with low amounts of Cdc20 are not tumor prone (Fig. 8 G). 
Also, the spectrum of spontaneous tumors in Cdc20
/H mice 
was similar to that of Cdc20
+/+ mice (Fig. S4).
Neuronal development is normal in Cdc20 
hypomorphic mice
Cdc20 knockdown experiments in postmitotic rat neurons sug-
gest that centrosome-associated Cdc20 controls the formation 
of primary, secondary, and tertiary dendritic branches (Kim et al., 
2009). These findings prompted us to screen Cdc20
/H pups for 
defects in dendrite morphogenesis. Primary cerebellar granule 
cells harvested from postnatal day 6 (P6) Cdc20
+/+ and Cdc20
/H 
mice  were  cultured  and  dendrite  branches  visualized  by   
immunostaining for MAP2. Although the overall dendrite length 
of Cdc20-depleted rat neurons is 2-3-fold reduced, no reduc-
tion in length was observed for Cdc20
/H neurons (Fig. S5,   
A and B). As judged by immunofluorescence staining for Cdc20 
and centrosomes, Cdc20
/H neurons showed no obvious reduc-
tion in centrosome-bound Cdc20 (Fig. S5 C), although overall 
Cdc20 levels were reduced (Fig. S5 D). Cdc20
/H MEFs also 
accumulated normal amounts of Cdc20 at centrosomes in inter-
phase (unpublished data). Thus, it seems that Cdc20 preferen-
tially targets to centrosomes, which might explain why dendrite 
morphogenesis was unperturbed in our model.
Cdc20 has also been implicated in presynaptic differentia-
tion (Yang et al., 2009), a process required for formation of syn-
apses and neuronal circuits during brain development. Cdc20 
presumably induces presynaptic differentiation by ordering the 
destruction of neuroD2, a neuronal transcription factor that in-
hibits formation of presynapsis by repressing complexin II gene 
transcription. To probe Cdc20
/H mice for defects in presynap-
tic differentiation, we measured neuroD2 levels in cerebellar 
lysates of P22 Cdc20
+/+ and Cdc20
/H mice by Western blot 
analysis. Unlike cerebellum of Cdc20-depleted rats (Yang   
et al., 2009), cerebellum of Cdc20
/H mice showed no elevated   
neuroD2 levels (Fig. S5 D). Furthermore, staining of brain sections 
of P26 Cdc20
+/+ and Cdc20
/H mice for synapsin I revealed that 
Cdc20 hypomorphism had no impact on the amount of synapses 
in the granular and molecular layers of the cerebellum (Fig. S5, 
E and F). Furthermore, Cdc20
/H mice showed no evidence of 
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Figure 8.  Cdc20 hypomorphic mice are not cancer prone despite aneuploidy. (A–C) Overall (A), skin (B), and lung (C) tumor incidence of DMBA-treated 
Cdc20
+/+, Cdc20
+/, Cdc20
H/H, and Cdc20
/H mice. Error bars represent 95% confidence intervals using the modified Wald method for proportions. 
There were no statistical differences between Cdc20 mutant and wild-type mice (by Fisher’s exact 
2 test). (D and E) Mean (D) and median (E) number 
of DMBA-induced lung tumors in mice of the indicated genotypes. Error bars in D represent SEM, and error bars in E represent nonparametric two-sided 
95% confidence intervals for the median. *, P = 0.0289 versus Cdc20
+/+ (by unpaired t test). (F) Kaplan–Meier overall survival curves of Cdc20
+/+ and 
Cdc20
/H mice. We note that Cdc20
/H mice remained indistinguishable from Cdc20
+/+ and developed no obvious pathologies. (G) Kaplan–Meier tumor-
free survival curves of mice that are presented in F. Animals that died without tumors were censored from the data.JCB • VOLUME 191 • NUMBER 2 • 2010   326
during mitosis is not restricted to cyclin B1, as demonstrated by 
a recent study showing that Cdc20 continues to be synthesized 
after mitosis onset as a means to counteract APC/C-mediated 
Cdc20 degradation in the presence of active mitotic checkpoint 
signaling (Nilsson et al., 2008). A recent study reported that 
Cdc20 transcripts undergo CPEB-regulated poly(A) tail elonga-
tion in mitotic HeLa cells (Novoa et al., 2010), suggesting that 
synthesis of cyclin B1 and Cdc20 during mitosis is orchestrated 
through a common mechanism. Mad2, securin, and cyclin A2 
protein levels were not impacted by inhibition of translation 
during mitosis (Fig. 5 C), which is consistent with a lack of CPE 
elements in transcripts encoding for these proteins.
Cdc20 depletion and tumorigenesis
Experiments  of  mutant  mice  that  are  prone  to  chromosome 
missegregation have provided compelling evidence for the hy-
pothesis that aneuploidy is causally implicated in tumor develop-
ment. Most mouse models of aneuploidy are predisposed to 
spontaneous tumors, whereas those that are not are typically 
prone to carcinogen-induced tumors. Also prone to various sponta-
neous tumors are mutant mice that suffer from APC/C
Cdc20 
hyperactivity caused by a Cdc20 mutation that prevents Mad2 
binding (Li et al., 2009). Our finding that Cdc20 hypomorphic 
mice were neither prone to spontaneous nor carcinogen-induced 
tumors is very surprising in light of this evidence. One could 
argue that the aneuploidy rates of Cdc20 hypomorphic mice 
might be too low, but this explanation is unlikely because 
chromosome counts on splenocytes and MEFs suggest that 
aneuploidy rates of several of the cancer-prone strains are in 
the same range as those of our Cdc20 hypomorphic mice.   
It is reasonable to assume that aneuploidy rates of splenocytes 
and MEFs are indicative of aneuploidies in other tissues and 
cell types, as indicated by chromosome counts on Cdc20 hypo-
morphic and wild-type lung fibroblasts. A recent study demon-
strated  that  inhibition  of  Cdc20  to  the  extent  that  it  blocks 
anaphase onset promotes programmed cell death of cancer cells 
in a mitotic checkpoint–independent fashion (Huang et al., 
2009). Although anaphase onset is not blocked in Cdc20 hypo-
morphic mice, it is significantly delayed. We speculate that this 
delay might slightly sensitize cells that are at risk for neoplastic 
transformation to apoptosis, thereby perhaps counteracting the 
tumor-promoting effect that aneuploidy of Cdc20 hypomorphic 
mice might have. Thus, Cdc20 hypomorphism might induce 
both tumor-suppressive and tumor-promoting effects that largely 
neutralize each other.
Materials and methods
Generation of Cdc20 mutant mice
The gene targeting procedure used to generate the hypomorphic Cdc20 
allele was as previously described (Dawlaty and van Deursen, 2006). Cor-
rectly targeted ES cell clones were injected into blastocysts, and Cdc20
+/H 
offspring were obtained from the resulting chimeras through standard pro-
cedures (Babu et al., 2003). The Cdc20
 allele used in our experiments 
was derived from gene trap ES clone XE368 (purchased from BayGenomics). 
DMBA tumor bioassays were performed as previously described (Babu 
et al., 2003). All mice used were on a 129 × C57BL/6 mixed genetic 
background. Cohorts of Cdc20
+/+ and Cdc20
–/H mice were monitored 
three times weekly for general health, well being, and tumor formation. At 
biopsy, spontaneous tumors were collected and processed for standard 
role in mitotic checkpoint signaling. Cdc20 fails to accumulate 
at high levels at kinetochores of misaligned chromosomes in 
hypomorphic cells, which might result in weakened checkpoint 
signaling and thus cause premature anaphase onset, chromo-
some missegregation, and aneuploidy. Although attractive, this 
scenario seems unlikely because like normal cells, Cdc20 hypo-
morphic cells undergo prolonged mitotic arrest in the presence 
of nocodazole, suggesting that their mitotic checkpoint is 
properly activated and maintained when Cdc20 levels are low. 
Moreover, if a checkpoint defect was to underlie chromosome 
misalignment, one would expect MG132 treatment to amelio-
rate the attachment phenotype rather than to aggravate it.
It is equally possible that the attachment phenotype of 
Cdc20 hypomorphic cells are caused by impaired APC/C
Cdc20 ac-
tivity in the mitotic cytosol. As a result of inadequate APC/C
Cdc20 
activity, Cdc20 hypomorphic cells retain high levels of cyclin 
B1 in metaphase, allowing cyclin B1–Cdk1 activity to per-
sist at a time that it should be rapidly declining. This leads to 
aberrant phosphorylation of substrates, as suggested by increased 
immunofluorescence of phosphorylated Cdk substrates in Cdc20 
hypomorphic metaphases, which may include regulators of MT–
kinetochore attachment, thereby perhaps altering their function. 
Consistent with this model, we find that chromosome misalign-
ment is the primary chromosome segregation defect of mutant 
MEFs that ectopically express cyclin B1 (unpublished data).
De novo cyclin B1 synthesis in mitosis
Cells with low amounts of Cdc20 show a remarkable increase in 
cyclin B1 levels that starts after NEBD and peaks in metaphase. 
Until now, de novo synthesis of cyclin B1 protein in M phase 
was thought to be limited to the first few divisions of frog 
embryogenesis. During M phase of these embryonic divisions, 
CPEB is known to regulate poly(A) tail extension of oocyte- 
derived cyclin B1 transcripts, thereby inducing translational 
activation (Groisman et al., 2002). This embryonic mechanism 
seems to be conserved in MEFs, as we find that de novo synthe-
sis of cyclin B1 in mitotic Cdc20 hypomorphic MEFs is depen-
dent on CPEB-binding sequences in the 3UTR of cyclin B1 
mRNA. We find that wild-type MEFs and HeLa cells promptly 
raise cyclin B1 protein levels in a translation-dependent fashion 
in response to nocodazole, suggesting that cyclin B1 synthesis 
in mitosis is not just a feature of Cdc20 hypomorphic cells. This 
notion is further supported by the observation that normal cells 
in metaphase exhibit reduced cyclin B1 levels after a brief   
period of translation inhibition.
Future studies will be needed to understand the biological 
significance of the newfound cyclin B1 synthesis in mitosis. How-
ever, one attractive model is that it serves to counteract cyclin B1 
proteolysis during prometaphase. As more and more kineto-
chores become attached to spindle MTs and mitotic checkpoint 
signaling starts to decline, APC/C
Cdc20 activity may gradually 
increase and drive cyclin B1 proteolysis in prometaphase. Perhaps, 
de novo synthesis of cyclin B1 in mitosis is particularly impor-
tant in situations where attachment errors that do not invoke the 
mitotic checkpoint would persist in late metaphase to provide 
sufficient time to correct such errors before anaphase onset and 
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in-house rabbit anti-mMad1 (510–998), rabbit anti–phospho-Ser Cdks 
substrate antibody (Cell Signaling), mouse anti–centrin 2 (provided by 
J. Salisbury, Mayo Clinic, Rochester, MN), rabbit anti-MAP2 (Millipore), 
rabbit anti-neuroD2 (Millipore), and mouse anti–synapsin I (Millipore).
Deconvolution microscopy
Microscopy was performed using a fluorescence microscope (IX70; Olympus) 
fitted with FITC, CY5, rhodamine, and DAPI filters and a digital camera 
(CoolSNAP HQ; Photometrics). Images were acquired using Resolve 3D as 
z stacks with 0.2-µm intervals using a U Plan Apo 100×/1.35 NA oil im-
mersion objective (Olympus). Images were deconvolved using SoftWoRx 
software (version 3.5.1; Applied Precision). When suitable kinetochore 
pairs were identified, the interkinetochore stretch was determined using the 
“distance measure” function in SoftWoRx. To determine interkinetochore 
distances of chromosomes in the absence of MT tension, cells were cultured 
in medium containing 10 µg/ml nocodazole for 1 h. Analysis of kinetochores 
with  cold  stable–stable  MT  attachments  were  as  described  previously 
(Lampson and Kapoor, 2005). ACA and -tubulin immunostaining were 
used to visualize kinetochores and MTs in deconvolved image z stacks. 
A kinetochore was scored as attached when an MT bundle ended at the 
kinetochore. Kinetochores for which the attachment status could not be 
determined with high fidelity because of MT crowding were excluded. At 
least 40 kinetochores were scored per genotype.
Plasmids
pVenus-N1/Hs-CcnB1  was  constructed  by  PCR  amplifying  Hs-CcnB1 
cDNA from pCMX-Hs-CcnB1-GFP (provided by J. Pines, Gurdon Institute, 
Cambridge,  England,  UK;  [forward  primer]  5-CTATACAAGCTTGCCA-
CCATGGCGCTCCGAGTCACCAGG-3 and [reverse primer] 5-CTATACG-
GATCCGTCACCTTGCCACAGCCTTGGC-3) and cloning it into HindIII–
BamHI cut pVenus-N1 (pEYFP-N1 [Takara Bio Inc.], in which EYFP was re-
placed with Venus). pVenus-N1/Hs-CcnB1/Ms-3UTR was generated by 
PCR amplifying the mouse cyclin B1 3UTR sequence from pBluescript SK-Ms-
CcnB1 (forward primer, 5-CGGGGTACCCCGGCGGCCGCCTCCAATA-
GACTGCTGCTACATCTGCAG-3; and reverse primer, 5-CGGGGTACCC-
CGGCGGCCGCAATTGTGAAAGCTTTCCACCAATAAATTTTA-3; Chapman 
and Wolgemuth, 1993) and ligating the polished PCR fragment into the 
EcoRV site of pVenus-N1/Hs-CcnB1. Insertion of the 3UTR sequence in the 
sense orientation yielded pVenus-N1/Hs-CcnB1/Ms-3UTR, and insertion 
in the antisense orientation yielded pVenus-N1/Hs-CcnB1/Ms-3UTR-AS.
Live cell imaging
For  chromosome  missegregation  analysis,  chromosome  movements  of 
H2B-YFP or H2B-mRFP–positive MEFs progressing through an unchallenged 
mitosis were followed at interframe intervals of 3 min as previously de-
scribed (Jeganathan et al., 2007). Destruction of securin-EYFP and cyclin 
B1–Venus was monitored as follows. H2B-mRFP expressing Cdc20
+/+ and 
Cdc20
/H MEFs were nucleofected with 5 mg pVenus-N1/Hs-CcnB1, pVenus-
N1/Hs-CcnB1/Ms-3UTR, pVenus-N1/Hs-CcnB1/Ms-3UTR-AS, or 2 mg 
pEYFP-N1-securin (provided by J. Pines) using a Nucleofector II (Lonza). 
Nucleofections were performed on 2 × 10
6 cells in MEF2 buffer (VPD-
1005; Lonza). Nucleofected MEFs were seeded into 35-mm glass-bottom 
dishes and analyzed 6–8 h later. G2 phase cells were marked, and im-
ages were captured every 3 min. Quantification of fluorescence levels was 
performed using ImageJ software as previously described (Wolthuis et al., 
2008). In brief, a line was drawn around the edge of the cell, and the 
mean pixel intensity was calculated. For the background subtraction pur-
poses, an open region was selected near the cell, and the mean pixel in-
tensity was calculated. The total cell fluorescence was calculated by (mean 
cell fluorescence)  (mean background fluorescence) × cell area.
Nocodazole and taxol challenge assays and mitotic timing experi-
ments were performed as previously described (Malureanu et al., 2009). 
For  mitotic  timing  experiments,  H2B-mRFP–positive  MEFs  progressing 
through an unchallenged mitosis were followed at interframe intervals of   
3 min, and the durations of prophase, prometaphase, metaphase, and 
anaphase were determined (Dawlaty et al., 2008). Note that cells with 
chromosome alignment and segregation errors were excluded from the 
analysis. AxioVision software (version 10.6) and PowerPoint (for Mac;   
Microsoft) were used for image processing, and Prism software (for Mac; 
version 4.0a; GraphPad Software, Inc.) was used for statistical analysis. At 
least three independent clones per genotype were used in the aforemen-
tioned experiments unless otherwise noted.
Analysis of dendrite morphogenesis
Cerebellar granule cell cultures were prepared from cerebella of 6-d-old 
Cdc20
+/+ and Cdc20
/H pups as described previously (Galvin et al., 2008). 
histopathology. All mouse experiments were conducted after approval of 
the Mayo Clinic Committee on Animal Care and Use. All mice were housed 
in a pathogen-free barrier environment. Mouse protocols were reviewed 
and approved by the institutional animal care and use committee.
Generation and culture of MEFs and chromosome counts
Cdc20 wild-type and mutant MEFs were generated and cultured as previ-
ously described (Baker et al., 2004). MEFs were frozen at passage 2 (P2) 
or 3 and used for experimentation between P4 and P6. At least three inde-
pendently generated MEF lines per genotype were used. Chromosome 
counts on mouse splenocytes, MEFs, and primary lung fibroblasts were as 
previously described (Babu et al., 2003; Baker et al., 2009). In karyotyping 
experiments in which MG132 was used, cells were cultured for 2 h in the pres-
ence of 10 µM of the drug. mMad2-shRNAmir clone V2MM_6980 was used 
to knockdown Mad2 in wild-type MEFs as described previously (Malureanu   
et al., 2009). BubR1
/ MEFs were prepared through Cre-mediated recombi-
nation as previously described (Malureanu et al., 2009).
Western blot analysis, indirect immunofluorescence,  
and confocal microscopy
Western blot analysis was performed as described previously (Kasper et al., 
1999). Tissue extracts were prepared in PBS containing 0.1% NP-40,   
10% glycerol, and complete protease inhibitor cocktail (Roche) using a 
gentleMACS dissociator (program m_impTumor_03 was run twice; Miltenyi 
Biotech). Extracts were centrifuged at 20,000 g for 15 min at 4°C, and super-
natants were collected for electrophoresis. To analyze de novo synthesis of 
cyclin B1 by Western blotting, mitotic HeLa cells were harvested from asyn-
chronous cultures (4 × 15–cm dishes) by shake off. Harvested cells were 
pelleted and cultured in medium containing 100 ng/ml nocodazole or 
100 ng/ml nocodazole plus 1 µg/ml CHX for 15 min at 37°C.
Indirect immunofluorescence was performed as described previously 
(Kasper et al., 1999; Taylor et al., 2001). Standard fixations for immuno-
stainings were with 3% paraformaldehyde for 12 min at RT. For kinetochore 
localization experiments, cells were fixed with 1% paraformaldehyde for   
5 min at RT. For localization of Cdc20 at centrosomes, cerebellar granule 
cell cultures were fixed with ice-cold methanol for 10 min at 20°C. CHX 
and nocodazole treatments were performed at 1 µg/ml and 100 ng/ml, 
respectively. A laser-scanning microscope (LSM 510 v3.2SP2; Carl Zeiss, 
Inc.) with Axiovert 100M (Carl Zeiss, Inc.) with a c-Apochromat 100× oil 
immersion objective was used to analyze immunostained cells and to cap-
ture  representative  images.  To  analyze  endogenous  cyclin  B1  levels, 
Cdc20
+/+ and Cdc20
/H MEFs were initially immunostained with two inde-
pendent mouse monoclonal antibodies against cyclin B1: GNS-1 (mouse 
anti–human  cyclin  B1;  Santa  Cruz  Biotechnology,  Inc.)  and  GNS-11 
(mouse anti–human cyclin B1; BD). By immunostaining of wild-type MEFs 
in which cyclin B1 was depleted with cyclin B1–shRNAmir lentivirus, we 
confirmed  that  immunofluorescence  signals  from  both  these  antibodies 
were specific for cyclin B1 protein. To measure endogenous cyclin A2 levels, 
MEFs were immunostained with rabbit anti–cyclin A2 (Santa Cruz Biotech-
nology, Inc.). For quantitation of cyclin B1 and cyclin A2 levels, we used 
ImageJ software (National Institutes of Health). Confocal images were con-
verted to 8-bit grayscale. Cell edges were traced using the freehand tool, 
and the mean pixel intensity within the marked area was calculated. The 
integrated density (in arbitrary units), defined as the mean pixel intensity 
multiplied by the area, was used as a measure for cyclin B1 and cyclin A2 
levels. For quantification of synapsin I signals, ImageJ software was used 
as follows. Confocal images were converted to 8-bit grayscale, and a 
“black and white” threshold of 0 to 22 or 0 to 45 was set up. Images were 
transformed to binary, and the “find edges” function was applied. The 
counts from “analyze particles” for 0–25 size were recorded for each 
field. Each field had a size of 93 × 93 µm. Random fields were manually 
counted to confirm the automated counting.
Antibodies
The following antibodies were used for immunofluorescence and Western blot-
ting: mouse anti–human cyclin B1 (Santa Cruz Biotechnology, Inc.) and mouse 
anti–human cyclin B1 (BD), rabbit anti–cyclin A2 (Santa Cruz Biotechnol-
ogy, Inc.), rabbit anti-Cdc20 (Santa Cruz Biotechnology, Inc.), in-house rabbit 
anti-Mad2, mouse anti–aurora B (BD), mouse anti–-actin (Sigma-Aldrich), 
mouse anti–-tubulin (Sigma-Aldrich), rabbit anti–human BubR1 (Baker et al., 
2004), human anti-centromere antibody (Antibodies, Inc.), mouse anti–human 
securin (Novus Biologicals), mouse anti–histone H3 phosphorylated at Ser10 
(Millipore), sheep anti–hamster MCAK (provided by L. Wordeman, University 
of Washington School of Medicine, Seattle, WA; Andrews et al., 2004),   
rabbit anti–mouse Bub1 (Jeganathan et al., 2007), rabbit anti–CENP-E (pro-
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In brief, the whole cerebellum was collected and dissociated. Suspended 
cells were plated on coverslips coated with 500 µg/ml poly-d-lysine. Plated 
cells were cultured overnight in neurobasal A medium (Invitrogen) supple-
mented with B-27 and glutamax I. After 24 h, medium was refreshed. After 
5 d in culture, granule cells were fixed for immunohistochemistry. For quan-
tification of total dendrite length of individual neurons, NeuronJ plug in 
(version 1.4.1; National Institutes of Health) for ImageJ was used. Images 
were converted to 8-bit grayscale, and tracings of all primary, secondary, and 
tertiary dendrites for individual neurons were measured and recorded.
Object recognition and rotarod tests
A scent-based object recognition test developed by Buenz et al. (2009) 
was used to test memory. In brief, a single mouse was placed in a 30 × 
30–cm acrylic box containing wood shavings. After 5 min, the animal was 
removed and held in a normal cage. Two berry-scented candles were 
placed in the acrylic box for the training session. The mouse was returned 
to the box and videotaped for the next 10 min to assess the number of inter-
rogations of each object. The mouse was relocated in a holding cage. One 
of the two berry-scented candles was replaced with an apple-scented can-
dle for the testing session. After 5 min, the mouse was returned to the box 
and videotaped for 10 min. The discrimination index was determined by 
dividing the number of interrogations of the novel object by the number of 
investigations of the control object. Normal recognition memory produces 
a discrimination index of about one for the training session and a discrimi-
nation index considerably greater than one for the testing session, which is 
consistent with greater interrogation of the novel object. Rotarod tests were 
performed as previously described (Brooks and Dunnett, 2009).
Online supplemental material
Fig. S1 shows that core mitotic checkpoint proteins properly target to kineto-
chores in early mitosis when Cdc20 levels are low. Fig. S2 shows that securin 
does not accumulate in Cdc20 hypomorphic MEFs. Fig. S3 shows that syn-
thesis of cyclin B1 during mitosis is transcription independent and provides 
a map of CPE consensus sequences in the 3UTR of cyclin B1. Fig. S4 
shows that the spontaneous tumor incidence and the tumor spectrum of 
Cdc20 hypomorphic mice are normal. Fig. S5 shows that dendrite mor-
phogenesis and presynaptic differentiation are not impaired in Cdc20 hypo-
morphic mice. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.201003090/DC1.
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